2021
DOI: 10.1097/mph.0000000000002310
|View full text |Cite
|
Sign up to set email alerts
|

Refractory Extracutaneous Juvenile Xanthogranuloma With Multiple Intracranial Nodular Lesions Successfully Treated With 2-Chlorodeoxyadenosine

Abstract: Juvenile xanthogranulomatosis (JXG) is a rare histiocytic disease that is usually limited to the skin, but some JXG cases involve other organs. JXG involving the central nervous system (CNS) is rare and its treatment is inadequate. The optimum treatment for refractory JXG involving the CNS remains unknown. We report here a case of refractory pediatric extracutaneous JXG (extra-JXG) involving the CNS with multiple intracranial masses treated with 2-chlorodeoxyadenosine resulting in achievement of long-term comp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 17 publications
(32 reference statements)
0
1
0
1
Order By: Relevance
“…Como tratamiento se han probado varias drogas sistémicas como la cladribina y vinblastine con buena respuesta; como último recurso se puede usar la radioterapia, la cual en niños se prefiere evitar. 13,15,19 Como diagnóstico diferencial debe tenerse en consideración la ERD, que suele presentarse en paciente entre 20 y 40 años, con lesiones cutáneas sistémicas y linfadenopatías cervicales, fiebre, sudoración nocturna, compromiso óseo y dural. Suele ser autolimitada, con períodos de exacerbaciones y remisión.…”
Section: Discussionunclassified
“…Como tratamiento se han probado varias drogas sistémicas como la cladribina y vinblastine con buena respuesta; como último recurso se puede usar la radioterapia, la cual en niños se prefiere evitar. 13,15,19 Como diagnóstico diferencial debe tenerse en consideración la ERD, que suele presentarse en paciente entre 20 y 40 años, con lesiones cutáneas sistémicas y linfadenopatías cervicales, fiebre, sudoración nocturna, compromiso óseo y dural. Suele ser autolimitada, con períodos de exacerbaciones y remisión.…”
Section: Discussionunclassified
“…Traditionally, the first‐line treatment of choice has been LCH‐based chemotherapy (vinblastine, prednisone, and mercaptopurine) for SJXG. There have also been reports on the successful use of cladribine and cytarabine for treating SJXG with CNS involvement 20 . Other management options include surgery, radiotherapy, and high doses of corticosteroids, cyclosporin A, methotrexate, and etoposide, all of which require greater awareness of their side effects when selected, especially in infancy and early childhood.…”
Section: The Treatment Modalities In Sjxgmentioning
confidence: 99%